Carregant...
Overview of FDA’s Expanded Access Program for Investigational Drugs
Expanded access, also called “compassionate use,” provides a pathway for patients to gain access to investigational drugs, biologics, and medical devices used to diagnose, monitor, or treat patients with serious diseases or conditions for which there are no comparable or satisfactory therapy options...
Guardat en:
| Publicat a: | Ther Innov Regul Sci |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5443564/ https://ncbi.nlm.nih.gov/pubmed/28553565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479017694850 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|